ITCI
Intra-Cellular Therapies Inc : RBC Cuts to Sector Perform From Outperform; Raises Target Price to $132 From $108
时间:2025-01-22 13:14:10 市场: 美股 综合
Intra-Cellular Therapies Inc : Needham Cuts to Hold From Buy
时间:2025-01-13 23:08:48 市场: 综合 美股
Intra-Cellular Therapies Shares Jump 34.6% After J&J to Acquire Co in $14.6 Bln Deal
时间:2025-01-13 22:31:21 市场: 美股 综合
Intra-Cellular Therapies Settles Caplyta® (Lumateperone) Patent Litigation With Sandoz
时间:2025-01-10 19:30:00 市场: 美股 综合
Intra-Cellular Therapies Reports Third Quarter 2024 Financial Results, Provides Corporate Update and Raises 2024 Caplyta Sales Guidance
时间:2024-10-30 19:30:35 市场: 美股 综合
Intra-Cellular Therapies Q3 Net Income USD -26.3 Million
时间:2024-10-30 19:30:35 市场: 美股 综合